On January 30, 2020 MedX Health Corp. ("MedX" or the "Company") (TSX-V:MDX) is reported that it has received Conditional Approval from the TSX Venture Exchange for a non-brokered Private Placement to accredited investors of up to 25,000,000 units at $0.12 per unit ("Unit"), to raise up to $3,000,000 (Press release, MedX Health, JAN 30, 2020, View Source [SID1234553718]). Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Common Share at the price of $0.20, exercisable for a period of two years from the date of issue. Closing of the Placement, which will take place in tranches, will be subject to receipt of subscriptions and a number of other conditions, including without limitation the receipt of all relevant regulatory and Stock Exchange approvals or acceptances. Qualified Agents may receive commissions in respect of subscriptions introduced by them by way of cash equal to 8% of funds so introduced, and issuance of agent’s warrants ("Agent’s Warrant(s)") equal in number to 8% of the number of units so subscribed for. Each Agent’s Warrant, which is non-transferable, will be exercisable to acquire one Unit at $0.12 per Unit, at any time during the period of two years following the Closing.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company further announces that on January 30, 2020, it closed a first tranche of the Private Placement by issuing a total of 1,485,000 Units, to raise $178,200 from accredited investors. The securities issued on January 30, 2020, will be restricted from trading for four months. In connection with this first Closing, a cash commission of $10,080 was paid and 84,000 Agent’s Warrants were issued. Following this first Closing, the Private Placement offering remains open for further subscriptions, subject to all relevant regulatory and other consents and approvals, including acceptance by the TSX Venture Exchange.